To the best of our knowledge, this is the first attempt to systematically review literature associating DPP4 and the gut microbiome in immune-mediated IBD, offering valuable insights into the bidirectional connection DPP4-gut microbiome, the intestinal disease pathogenesis, and potential therapeutic interventions. Here, DPP4 is linked to inflammatory bowel disease.